estrogen receptor-positive (ER+) breast cancer.

September 17, 2018

Online Test Measures Women’s Risk of Cancer Recurrence or Spread After Hormone Therapy

News

A newly developed online prognostic tool can determine whether a woman is at high risk of cancer recurrence or spread after receiving the standard five years of hormone therapy, and ... Read more

May 30, 2018

Regardless of Age, Surgery Best for Most Early-stage Breast Cancers, Study Says

News

Women 70 or older who were diagnosed with estrogen receptor-positive breast cancer had higher mortality rates when treated with endocrine therapies compared to surgery, a recent U.K. study shows. The ... Read more